1 December 2024 false No description of principal activity Taxfiler 2024.6 09322197business:PrivateLimitedCompanyLtd2024-12-012025-11-30 093221972024-11-30 093221972024-12-012025-11-30 09322197business:AuditExempt-NoAccountantsReport2024-12-012025-11-30 09322197business:FilletedAccounts2024-12-012025-11-30 093221972025-11-30 09322197business:Director12024-12-012025-11-30 093221972024-11-30 09322197core:WithinOneYear2025-11-30 09322197core:WithinOneYear2024-11-30 09322197core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 09322197core:ShareCapitalcore:PreviouslyStatedAmount2024-11-30 09322197core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 09322197core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-11-30 09322197core:PreviouslyStatedAmount2025-11-30 09322197core:PreviouslyStatedAmount2024-11-30 09322197business:SmallEntities2024-12-012025-11-30 09322197countries:EnglandWales2024-12-012025-11-30 09322197core:Goodwill2024-11-30 09322197core:Goodwill2025-11-30 09322197core:FurnitureFittings2024-11-30 09322197core:ComputerEquipment2024-11-30 09322197core:FurnitureFittings2024-12-012025-11-30 09322197core:ComputerEquipment2024-12-012025-11-30 09322197core:FurnitureFittings2025-11-30 09322197core:ComputerEquipment2025-11-30 093221972023-12-012024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 09322197 (England and Wales)
Mmr Pharma Ltd Unaudited accounts for the year ended 30 November 2025
Mmr Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Mmr Pharma Ltd Company Information for the year ended 30 November 2025
Director
Mohammed Muzamal RAFIQUE
Company Number
09322197 (England and Wales)
- 3 -
Mmr Pharma Ltd Statement of financial position as at 30 November 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Intangible assets
4
290,000 
290,000 
Tangible assets
5
5,226 
6,648 
295,226 
296,648 
Current assets
Inventories
39,850 
14,650 
Cash at bank and in hand
145,201 
54,888 
185,051 
69,538 
Creditors: amounts falling due within one year
6
(386,708)
(386,138)
Net current liabilities
(201,657)
(316,600)
Net assets/(liabilities)
93,569 
(19,952)
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
93,568 
(19,953)
Shareholders' funds
93,569 
(19,952)
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 August 2026 and were signed on its behalf by
Mohammed Muzamal RAFIQUE Director Company Registration No. 09322197
- 4 -
Mmr Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Mmr Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 09322197.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 December 2024
290,000 
At 30 November 2025
290,000 
Amortisation
At 1 December 2024
- 
At 30 November 2025
- 
Net book value
At 30 November 2025
290,000 
At 30 November 2024
290,000 
5
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 December 2024
275 
6,373 
6,648 
Disposals
(275)
- 
(275)
At 30 November 2025
- 
6,373 
6,373 
Depreciation
Charge for the year
- 
1,147 
1,147 
At 30 November 2025
- 
1,147 
1,147 
Net book value
At 30 November 2025
- 
5,226 
5,226 
At 30 November 2024
275 
6,373 
6,648 
- 5 -
Mmr Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
207,008 
227,500 
Trade creditors
58,337 
25,588 
Taxes and social security
21,948 
- 
Other creditors
95,888 
133,050 
Accruals
3,527 
- 
386,708 
386,138 
7
Average number of employees
During the year the average number of employees was 3 (2024: 0).
- 6 -